1. Home
  2. TNXP vs NCMI Comparison

TNXP vs NCMI Comparison

Compare TNXP & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$9.26

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

N/A

Current Price

$2.09

Market Cap

207.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
TNXP
NCMI
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
207.0M
IPO Year
2008
2006

Fundamental Metrics

Financial Performance
Metric
TNXP
NCMI
Price
$9.26
$2.09
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
★ $44.50
$4.75
AVG Volume (30 Days)
374.3K
★ 900.8K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 4.02%
EPS Growth
★ 91.75
52.17
EPS
N/A
★ N/A
Revenue
★ $13,107,000.00
N/A
Revenue This Year
$319.65
$8.57
Revenue Next Year
$101.60
$3.59
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 29.85
N/A
52 Week Low
$9.40
$2.11
52 Week High
$24.64
$4.56

Technical Indicators

Market Signals
Indicator
TNXP
NCMI
Relative Strength Index (RSI) 26.70 37.23
Support Level $9.40 $2.14
Resistance Level $12.99 $3.72
Average True Range (ATR) 0.50 0.11
MACD -0.18 0.03
Stochastic Oscillator 3.73 31.43

Price Performance

Historical Comparison
TNXP
NCMI

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: